Faruqi & Faruqi Encourages Investors in Picard Medical to Reach Out
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 06 2026
0mins
Should l Buy PMI?
Source: PRnewswire
- Legal Investigation: Faruq & Faruqi is investigating potential claims against Picard Medical for securities purchased between September 2, 2025, and October 31, 2025, indicating possible legal risks that could undermine investor confidence in the company.
- Investor Contact Information: Investors who suffered losses during the specified period are encouraged to contact securities litigation partner Josh Wilson directly, with two provided phone numbers, reflecting the firm's commitment to supporting affected investors.
- Class Action Deadline: The firm reminds investors of the April 3, 2026, deadline to seek the role of lead plaintiff in the federal securities class action against Picard Medical, emphasizing the urgency for investors to act promptly.
- Market Impact: This investigation and potential class action could negatively affect Picard Medical's stock price, prompting investors to monitor developments closely to adjust their investment strategies and mitigate potential losses.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PMI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PMI
About PMI
Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Class Action Lawsuit Filed Against Picard Medical, Inc.
- Class Action Initiation: Picard Medical, Inc. (NYSE:PMI) faces a class action lawsuit for issuing false and misleading statements between September 2 and October 31, 2025, affecting all investors who purchased shares during this period, indicating significant legal risks for the company.
- Investor Rights Advocacy: The law firm Wolf Haldenstein Adler Freeman & Herz LLP, established in 1888, boasts over 125 years of experience in securities litigation, dedicated to pursuing justice for investors harmed by the company's misrepresentations, highlighting the firm's expertise and reliability.
- Lead Plaintiff Application Deadline: Investors must apply to be lead plaintiffs by April 3, 2026, underscoring the urgency for investors in the legal process, which may also impact their decision-making and market confidence.
- Call for Legal Consultation: The law firm encourages all affected investors or those with relevant information to reach out, demonstrating the firm's commitment to the case and the protection of investor rights.
See More
Reminder of Class Action Lawsuit for Picard Medical Investors
- Stock Price Crash: On October 23, 2025, Picard Medical's stock plummeted approximately 70% during after-hours trading, falling from $13.20 to $3.99 per share, resulting in significant losses for investors and reflecting a sharp decline in market confidence in the company.
- Fraud Allegations: The lawsuit alleges that throughout the class period from September 2 to October 31, 2025, Picard failed to disclose that its stock was subject to a fraudulent social media promotion scheme, misleading investors about the company's prospects and exacerbating their losses.
- Insider Trading: Investigations revealed that insiders used offshore or nominee accounts to facilitate coordinated stock dumping during the price inflation campaign, failing to disclose this information to investors, which damaged the company's reputation and triggered legal action.
- Legal Action Deadline: Investors must file a motion by April 3, 2026, to request appointment as lead plaintiff in the class action lawsuit to recover losses incurred due to false information, highlighting the importance of investor protection.
See More
Class Action Lawsuit Filed Against Picard Medical, Inc.
- Class Action Initiation: A class action lawsuit has been filed against Picard Medical for allegedly issuing false statements between September 2 and October 31, 2025, with investors having until April 3, 2026, to seek lead plaintiff status, highlighting serious concerns over the company's transparency and integrity.
- False Promotion Allegations: The complaint alleges that Picard was involved in a fraudulent stock promotion scheme utilizing social media misinformation and impersonation of financial professionals, which artificially inflated stock prices and could lead to significant financial losses for investors.
- Insider Trading Investigation: The lawsuit also claims that insiders or affiliates used offshore accounts to facilitate coordinated share dumping, exacerbating stock price volatility and indicating potential flaws in the company's governance structure.
- Law Firm Credentials: Wolf Haldenstein Adler Freeman & Herz LLP, founded in 1888, boasts over 125 years of experience in securities litigation, dedicated to pursuing justice for investors harmed by misrepresented statements, underscoring its authority in the legal field.
See More
Multiple Companies Face Class Action Lawsuits
- Richtech Robotics Class Action: Richtech Robotics Inc. faces a class action lawsuit for the period from January 27 to January 29, 2026, alleging failure to disclose a false collaboration with Microsoft, misleading investors about the company's prospects, with a lead plaintiff motion deadline of April 3, 2026.
- Picard Medical Allegations: Picard Medical, Inc. is implicated in a class action lawsuit for the period from September 2 to October 31, 2025, accused of engaging in fraudulent stock promotion schemes and insider trading, with the same lead plaintiff motion deadline of April 3, 2026, resulting in investor losses.
- Plug Power Lawsuit Context: Plug Power, Inc. is involved in a class action lawsuit for the period from January 17 to November 13, 2025, accused of overstating the availability of funds related to a DOE loan, misleading investors about future projects, with a lead plaintiff motion deadline of April 3, 2026.
- Legal Consultation Recommendation: Investors suffering losses in these companies are advised to contact The Law Offices of Frank R. Cruz to understand their legal rights, and they need not take immediate action to become members of the class action.
See More
Picard Medical Securities Class Action Notice Issued
- Class Action Initiation: Rosen Law Firm reminds investors who purchased Picard Medical (NYSE American: PMI) securities between September 2 and October 31, 2025, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- False Statements Uncovered: The lawsuit alleges that Picard Medical's management failed to disclose significant adverse facts regarding the company's business and securities trading during the class period, including a fraudulent stock promotion scheme involving social media misinformation and insider selling activities, misleading investors.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its success and expertise in this field.
- Investor Guidance: The firm advises investors to select qualified counsel with a proven track record, avoiding inexperienced middlemen, to ensure optimal legal support and potential recovery in the class action lawsuit.
See More
Picard Medical Faces Class Action Over Fraudulent Stock Promotion Allegations
- Lawsuit Reminder: Robbins LLP reminds all investors who purchased or acquired Picard Medical (NYSE:PMI) securities between September 2, 2025, and October 31, 2025, that a class action has been filed, indicating potential losses for shareholders.
- Fraud Allegations: The complaint alleges that Picard Medical failed to disclose its involvement in a fraudulent stock promotion scheme utilizing social media misinformation and impersonated financial professionals, misleading investors significantly.
- Stock Price Crash: On October 24, 2025, Picard Medical's stock price plummeted by 70%, dropping from $13.30 to $3.99 per share, and has since continued to decline to approximately $2.00 per share, reflecting a severe crisis of market trust for the company.
- Shareholder Action: Shareholders can file papers by April 3, 2026, to serve as lead plaintiffs in the class action, representing other shareholders and highlighting the urgent need for improved corporate governance to protect investor rights.
See More
Class Action Lawsuit Filed Against Picard Medical, Inc.
- Class Action Initiation: Picard Medical, Inc. (NYSE:PMI) faces a class action lawsuit for issuing false and misleading statements between September 2 and October 31, 2025, affecting all investors who purchased shares during this period, indicating significant legal risks for the company.
- Investor Rights Advocacy: The law firm Wolf Haldenstein Adler Freeman & Herz LLP, established in 1888, boasts over 125 years of experience in securities litigation, dedicated to pursuing justice for investors harmed by the company's misrepresentations, highlighting the firm's expertise and reliability.
- Lead Plaintiff Application Deadline: Investors must apply to be lead plaintiffs by April 3, 2026, underscoring the urgency for investors in the legal process, which may also impact their decision-making and market confidence.
- Call for Legal Consultation: The law firm encourages all affected investors or those with relevant information to reach out, demonstrating the firm's commitment to the case and the protection of investor rights.
See More
Reminder of Class Action Lawsuit for Picard Medical Investors
- Stock Price Crash: On October 23, 2025, Picard Medical's stock plummeted approximately 70% during after-hours trading, falling from $13.20 to $3.99 per share, resulting in significant losses for investors and reflecting a sharp decline in market confidence in the company.
- Fraud Allegations: The lawsuit alleges that throughout the class period from September 2 to October 31, 2025, Picard failed to disclose that its stock was subject to a fraudulent social media promotion scheme, misleading investors about the company's prospects and exacerbating their losses.
- Insider Trading: Investigations revealed that insiders used offshore or nominee accounts to facilitate coordinated stock dumping during the price inflation campaign, failing to disclose this information to investors, which damaged the company's reputation and triggered legal action.
- Legal Action Deadline: Investors must file a motion by April 3, 2026, to request appointment as lead plaintiff in the class action lawsuit to recover losses incurred due to false information, highlighting the importance of investor protection.
See More
Class Action Lawsuit Filed Against Picard Medical, Inc.
- Class Action Initiation: A class action lawsuit has been filed against Picard Medical for allegedly issuing false statements between September 2 and October 31, 2025, with investors having until April 3, 2026, to seek lead plaintiff status, highlighting serious concerns over the company's transparency and integrity.
- False Promotion Allegations: The complaint alleges that Picard was involved in a fraudulent stock promotion scheme utilizing social media misinformation and impersonation of financial professionals, which artificially inflated stock prices and could lead to significant financial losses for investors.
- Insider Trading Investigation: The lawsuit also claims that insiders or affiliates used offshore accounts to facilitate coordinated share dumping, exacerbating stock price volatility and indicating potential flaws in the company's governance structure.
- Law Firm Credentials: Wolf Haldenstein Adler Freeman & Herz LLP, founded in 1888, boasts over 125 years of experience in securities litigation, dedicated to pursuing justice for investors harmed by misrepresented statements, underscoring its authority in the legal field.
See More
Multiple Companies Face Class Action Lawsuits
- Richtech Robotics Class Action: Richtech Robotics Inc. faces a class action lawsuit for the period from January 27 to January 29, 2026, alleging failure to disclose a false collaboration with Microsoft, misleading investors about the company's prospects, with a lead plaintiff motion deadline of April 3, 2026.
- Picard Medical Allegations: Picard Medical, Inc. is implicated in a class action lawsuit for the period from September 2 to October 31, 2025, accused of engaging in fraudulent stock promotion schemes and insider trading, with the same lead plaintiff motion deadline of April 3, 2026, resulting in investor losses.
- Plug Power Lawsuit Context: Plug Power, Inc. is involved in a class action lawsuit for the period from January 17 to November 13, 2025, accused of overstating the availability of funds related to a DOE loan, misleading investors about future projects, with a lead plaintiff motion deadline of April 3, 2026.
- Legal Consultation Recommendation: Investors suffering losses in these companies are advised to contact The Law Offices of Frank R. Cruz to understand their legal rights, and they need not take immediate action to become members of the class action.
See More
Picard Medical Securities Class Action Notice Issued
- Class Action Initiation: Rosen Law Firm reminds investors who purchased Picard Medical (NYSE American: PMI) securities between September 2 and October 31, 2025, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- False Statements Uncovered: The lawsuit alleges that Picard Medical's management failed to disclose significant adverse facts regarding the company's business and securities trading during the class period, including a fraudulent stock promotion scheme involving social media misinformation and insider selling activities, misleading investors.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its success and expertise in this field.
- Investor Guidance: The firm advises investors to select qualified counsel with a proven track record, avoiding inexperienced middlemen, to ensure optimal legal support and potential recovery in the class action lawsuit.
See More
Picard Medical Faces Class Action Over Fraudulent Stock Promotion Allegations
- Lawsuit Reminder: Robbins LLP reminds all investors who purchased or acquired Picard Medical (NYSE:PMI) securities between September 2, 2025, and October 31, 2025, that a class action has been filed, indicating potential losses for shareholders.
- Fraud Allegations: The complaint alleges that Picard Medical failed to disclose its involvement in a fraudulent stock promotion scheme utilizing social media misinformation and impersonated financial professionals, misleading investors significantly.
- Stock Price Crash: On October 24, 2025, Picard Medical's stock price plummeted by 70%, dropping from $13.30 to $3.99 per share, and has since continued to decline to approximately $2.00 per share, reflecting a severe crisis of market trust for the company.
- Shareholder Action: Shareholders can file papers by April 3, 2026, to serve as lead plaintiffs in the class action, representing other shareholders and highlighting the urgent need for improved corporate governance to protect investor rights.
See More
